Welldoc Achieves Significant Digital Health Milestone by Securing Its 10th Patent for Its BlueStar® Digital Therapeutic
07 janv. 2019 09h08 HE
|
WellDoc Inc.
COLUMBIA, Md., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Welldoc, a leading digital health company, announced today that it has secured a technology patent (based on U.S. Patent Application No. 15/923,010)...
Digital Health Transformation Leader Daniel Garrett, Former PwC Partner, Joins Welldoc® Board of Directors
30 août 2018 09h00 HE
|
WellDoc Inc.
BALTIMORE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Welldoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital...
Welldoc® to Highlight Adoption of Digital Therapeutics for Improving Diabetes Care with Five Poster Presentations at AADE 2018 Annual Meeting
17 août 2018 09h00 HE
|
WellDoc Inc.
BALTIMORE, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Welldoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital...
WellDoc®’s BlueStar® Now Available for Hypertension and Weight Management
09 juil. 2018 09h00 HE
|
WellDoc Inc.
BALTIMORE, July 09, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, today announces hypertension and weight management solutions integrated within its digital therapeutic app...
WellDoc® Presents Results of an Innovative Economic Analysis Demonstrating Opportunity for Significant Healthcare Cost Savings with the Use of BlueStar®
26 juin 2018 09h03 HE
|
WellDoc Inc.
BALTIMORE, Md., June 26, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital...
WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes
03 avr. 2018 09h00 HE
|
WellDoc Inc.
COLUMBIA, Md., April 03, 2018 (GLOBE NEWSWIRE) -- Today, WellDoc® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s...
Solera Health and WellDoc Partner to Offer Health Plans and Employers a Holistic Approach to Diabetes Prevention and Management
17 janv. 2018 10h00 HE
|
Solera Health; WellDoc
PHOENIX and COLUMBIA, Md., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Solera Health, an integrated benefit network, and WellDoc®, a leading digital therapeutic company, announced today that WellDoc’s...
Voluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic Offerings
09 janv. 2018 09h00 HE
|
WellDoc Inc.
CAMBRIDGE, Mass. and COLUMBIA, Md., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial agreement...
WellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare Costs
04 janv. 2018 09h00 HE
|
WellDoc Inc.
COLUMBIA, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital...
IQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes Treatment
13 nov. 2017 10h52 HE
|
WellDoc Inc.
COLUMBIA, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, announced today that IQVIA Institute for Human Data Science (formerly Quintiles/IMS) named BlueStar®,...